Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Toward precision interventions and metrics of inflammaging

Abstract

Inflammaging describes a chronic, systemic, low-grade inflammatory state that is recognized as a major risk factor for age-related diseases (ARDs) and a pivotal convergence point of multiple biological mechanisms involved in aging. Here, we discuss the heterogeneity of inflammaging, proposing that it emerges as a consequence of each individual’s lifelong exposures to inflammatory stimuli, shaped by a unique combination of genetics, lifestyle, socioeconomic conditions and environmental factors such as infections and pollution. Through this lens, we then discuss measuring inflammaging, describing the development of inflammatory clocks that quantify inflammatory age and show strong associations with ARD incidence as well as how other aging clocks intersect with inflammaging. Finally, we consider interventions that may counteract inflammaging, including nutritional interventions, physical activity and gerotherapies such as senolytics. We propose that deepening our knowledge of the individual nature of inflammaging stands to enhance our understanding of personalized aging trajectories and inform precision interventions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Main sources and mechanisms underlying personalized inflammaging.
Fig. 2: Local explainability of AI-based SImAge clock illustrated by waterfall plots.
Fig. 3: Personalized anti-inflammaging treatments.
Fig. 4: Personalized explainable inflammaging clocks.

Similar content being viewed by others

References

  1. Franceschi, C. et al. Inflamm‐aging: an evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244–254 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576–590 (2018).

    Article  CAS  PubMed  Google Scholar 

  3. Fulop, T. et al. Immunology of aging: the birth of inflammaging. Clin. Rev. Allergy Immunol. 64, 109–122 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Santoro, A., Bientinesi, E. & Monti, D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res. Rev. 71, 101422 (2021).

    Article  CAS  PubMed  Google Scholar 

  5. Franceschi, C. et al. The network and the remodeling theories of aging: historical background and new perspectives. Exp. Gerontol. 35, 879–896 (2000).

    Article  CAS  PubMed  Google Scholar 

  6. Fulop, T., Witkowski, J. M., Olivieri, F. & Larbi, A. The integration of inflammaging in age-related diseases. Semin. Immunol. 40, 17–35 (2018).

    Article  CAS  PubMed  Google Scholar 

  7. Kerepesi, C., Zhang, B., Lee, S.-G., Trapp, A. & Gladyshev, V. N. Epigenetic clocks reveal a rejuvenation event during embryogenesis followed by aging. Sci. Adv. 7, eabg6082 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Franceschi, C., Ostan, R. & Santoro, A. Nutrition and inflammation: are centenarians similar to individuals on calorie-restricted diets? Annu. Rev. Nutr. 38, 329–356 (2018).

    Article  CAS  PubMed  Google Scholar 

  9. Fulop, T. et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front. Immunol. 8, 1960 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Remondini, D. et al. Identification of a T cell gene expression clock obtained by exploiting a MZ twin design. Sci. Rep. 7, 6005 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Franceschi, C. et al. Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front. Immunol. 8, 982 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Audi, R The Cambridge Dictionary of Philosophy (Cambridge Univ. Press, 1999).

  13. Brodin, P. & Davis, M. M. Human immune system variation. Nat. Rev. Immunol. 17, 21–29 (2017).

    Article  CAS  PubMed  Google Scholar 

  14. Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lyons, C. E. et al. Chronic social stress induces p16-mediated senescent cell accumulation in mice. Nat. Aging 5, 48–64 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Marfella, R. et al. Microplastics and nanoplastics in atheromas and cardiovascular events. N. Engl. J. Med. 390, 900–910 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kwiatkowska, K. M. et al. Heterogeneity of cellular senescence: cell type-specific and senescence stimulus-dependent epigenetic alterations. Cells 12, 927 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Muscatell, K. A., Brosso, S. N. & Humphreys, K. L. Socioeconomic status and inflammation: a meta-analysis. Mol. Psychiatry 25, 2189–2199 (2020).

    Article  PubMed  Google Scholar 

  19. Hamilton, O. S. & Steptoe, A. Socioeconomic determinants of inflammation and neuroendocrine activity: a longitudinal analysis of compositional and contextual effects. Brain Behav. Immun. 107, 276–285 (2023).

    Article  CAS  PubMed  Google Scholar 

  20. Kivimäki, M. et al. Social disadvantage accelerates aging. Nat. Med. 31, 1635–1643 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Natale, B. N. et al. Systemic inflammation contributes to the association between childhood socioeconomic disadvantage and midlife cardiometabolic risk. Ann. Behav. Med. 57, 26–37 (2023).

    Article  PubMed  Google Scholar 

  22. Gireesh, A., Sacker, A., McMunn, A. & Cadar, D. Role of inflammation in the socioeconomic inequalities of neurocognitive disorders. Brain Behav. Immun. 113, 203–211 (2023).

    Article  PubMed  Google Scholar 

  23. Noppert, G. A., Stebbins, R. C., Dowd, J. B. & Aiello, A. E. Socioeconomic and race/ethnic differences in immunosenescence: evidence from the Health and Retirement Study. Brain Behav. Immun. 107, 361–368 (2023).

    Article  CAS  PubMed  Google Scholar 

  24. Ye, X. et al. Associations of socioeconomic status with infectious diseases mediated by lifestyle, environmental pollution and chronic comorbidities: a comprehensive evaluation based on UK Biobank. Infect. Dis. Poverty 12, 5 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Tang, B., Li, Z., Hu, S. & Xiong, J. Economic implications of health care burden for elderly population. Inquiry 59, 469580221121511 (2022).

  26. Solovev, I. et al. Aging and physiological barriers: mechanisms of barrier integrity changes and implications for age-related diseases. Mol. Biol. Rep. 51, 917 (2024).

    Article  CAS  PubMed  Google Scholar 

  27. Franceschi, C., Garagnani, P., Vitale, G., Capri, M. & Salvioli, S. Inflammaging and ‘garb-aging’. Trends Endocrinol. Metab. 28, 199–212 (2017).

    Article  CAS  PubMed  Google Scholar 

  28. Franceschi, C. et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92–105 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Olivieri, F., Prattichizzo, F., Lattanzio, F., Bonfigli, A. R. & Spazzafumo, L. Antifragility and antiinflammaging: can they play a role for a healthy longevity? Ageing Res. Rev. 84, 101836 (2023).

    Article  CAS  PubMed  Google Scholar 

  30. Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Santoro, A. et al. Inflammaging, hormesis and the rationale for anti-aging strategies. Ageing Res. Rev. 64, 101142 (2020).

    Article  CAS  PubMed  Google Scholar 

  32. Storci, G. et al. Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell Death Differ. 26, 1845–1858 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sayed, N. et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat. Aging 1, 598–615 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Baker, C., Kim, M. & Benayoun, B. A. A researcher’s guide to studying sex differences in immune aging. Trends Mol. Med. https://doi.org/10.1016/j.molmed.2025.01.005 (2025).

    Article  PubMed  Google Scholar 

  35. Márquez, E. J. et al. Sexual-dimorphism in human immune system aging. Nat. Commun. 11, 751 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  36. Martínez de Toda, I. et al. Sex differences in markers of oxidation and inflammation. Implications for ageing. Mech. Ageing Dev. 211, 111797 (2023).

    Article  PubMed  Google Scholar 

  37. Ostan, R. et al. Gender, aging and longevity in humans: an update of an intriguing/neglected scenario paving the way to a gender-specific medicine. Clin. Sci. 130, 1711–1725 (2016).

    Article  Google Scholar 

  38. de Assunção Cortez Corrêa, L. C., Raffin, J., Vellas, B., Guerra, R. O. & de Souto Barreto, P. Sex-specific associations of neurodegeneration and inflammatory biomarkers with intrinsic capacity in older adults: findings from the 4-year longitudinal Multidomain Alzheimer’s Prevention Trial (MAPT). Maturitas 193, 108191 (2025).

    Article  PubMed  Google Scholar 

  39. Bronikowski, A. M. et al. Sex‐specific aging in animals: perspective and future directions. Aging Cell 21, e13542 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Ungvari, A. et al. Sex-specific mechanisms in vascular aging: exploring cellular and molecular pathways in the pathogenesis of age-related cardiovascular and cerebrovascular diseases. Geroscience 47, 301–337 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  41. Barbieri, M. et al. Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors. Ageing Res. Rev. 99, 102405 (2024).

    Article  CAS  PubMed  Google Scholar 

  42. Olivieri, F. et al. Sex/gender-related differences in inflammaging. Mech. Ageing Dev. 211, 111792 (2023).

    Article  CAS  PubMed  Google Scholar 

  43. Tylutka, A., Walas, Ł. & Zembron-Lacny, A. Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis. Front. Immunol. 15, 1330386 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kalyakulina, A. et al. Inflammaging markers in the extremely cold climate: a case study of Yakutian population. Int. J. Mol. Sci. 25, 13741 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Alpert, A. et al. A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring. Nat. Med. 25, 487–495 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Yusipov, I. et al. Accelerated epigenetic aging and inflammatory/immunological profile (ipAGE) in patients with chronic kidney disease. Geroscience 44, 817–834 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Kalyakulina, A., Yusipov, I., Moskalev, A., Franceschi, C. & Ivanchenko, M. Explainable artificial intelligence (XAI) in aging clock models. Ageing Res. Rev. 93, 102144 (2024).

    Article  CAS  PubMed  Google Scholar 

  48. Markov, N. T. et al. Age-related brain atrophy is not a homogenous process: different functional brain networks associate differentially with aging and blood factors. Proc. Natl Acad. Sci. USA 119, e2207181119 (2022).

  49. Widjaja, A. A. et al. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. Nature 632, 157–165 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843–1850 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lehallier, B., Shokhirev, M. N., Wyss‐Coray, T. & Johnson, A. A. Data mining of human plasma proteins generates a multitude of highly predictive aging clocks that reflect different aspects of aging. Aging Cell 19, e13256 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Argentieri, M. A. et al. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nat. Med. 30, 2450–2460 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Hällqvist, J. et al. Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset. Nat. Commun. 15, 4759 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 19, 371–384 (2018).

    Article  CAS  PubMed  Google Scholar 

  55. Crimmins, E. M., Klopack, E. T. & Kim, J. K. Generations of epigenetic clocks and their links to socioeconomic status in the Health and Retirement Study. Epigenomics 16, 1031–1042 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Yusipov, I., Kalyakulina, A., Trukhanov, A., Franceschi, C. & Ivanchenko, M. Map of epigenetic age acceleration: a worldwide analysis. Ageing Res. Rev. 100, 102418 (2024).

    Article  CAS  PubMed  Google Scholar 

  57. Zaghlool, S. B. et al. Epigenetics meets proteomics in an epigenome-wide association study with circulating blood plasma protein traits. Nat. Commun. 11, 15 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Stevenson, A. J. et al. Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. Clin. Epigenetics 12, 113 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Stevenson, A. J. et al. Creating and validating a DNA methylation-based proxy for interleukin-6. J. Gerontol. A Biol. Sci. Med. Sci. 76, 2284–2292 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Gadd, D. A. et al. Correction: Epigenetic scores for the circulating proteome as tools for disease prediction. eLife 12, e94481 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  61. Bernabeu, E. et al. Refining epigenetic prediction of chronological and biological age. Genome Med. 15, 12 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Kalyakulina, A. et al. EpInflammAge: epigenetic-inflammatory clock for disease-associated biological aging based on deeplearning. Int. J. Mol. Sci. 26, 6284 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Ahadi, S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat. Med. 26, 83–90 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Prattichizzo, F. et al. Organ-specific biological clocks: ageotyping for personalized anti-aging medicine. Ageing Res. Rev. 96, 102253 (2024).

    Article  PubMed  Google Scholar 

  65. Jung, A. M. et al. Associations between epigenetic age acceleration and microRNA expression among U.S. firefighters. Epigenet. Insights 16, 25168657231206301 (2023).

  66. Salignon, J. et al. Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis. Aging 15, 5240–5265 (2023).

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Roig-Genoves, J. V., García-Giménez, J. L. & Mena-Molla, S. A miRNA-based epigenetic molecular clock for biological skin-age prediction. Arch. Dermatol. Res. 316, 326 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  68. Martucci, M. et al. Mediterranean diet and inflammaging within the hormesis paradigm. Nutr. Rev. 75, 442–455 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  69. Izquierdo, M. et al. International Exercise Recommendations in Older Adults (ICFSR): expert consensus guidelines. J. Nutr. Health Aging 25, 824–853 (2021).

    Article  CAS  PubMed  Google Scholar 

  70. Gensous, N. et al. One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project. Geroscience 42, 687–701 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  71. Gialluisi, A. et al. Epidemiological and genetic overlap among biological aging clocks: new challenges in biogerontology. Ageing Res. Rev. 72, 101502 (2021).

    Article  CAS  PubMed  Google Scholar 

  72. Ghosh, T. S. et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 69, 1218–1228 (2020).

    Article  CAS  PubMed  Google Scholar 

  73. Moskalev, A. et al. Targeting aging mechanisms: pharmacological perspectives. Trends Endocrinol. Metab. 33, 266–280 (2022).

    Article  CAS  PubMed  Google Scholar 

  74. Di Giosia, P. et al. The role of nutrition in inflammaging. Ageing Res. Rev. 77, 101596 (2022).

    Article  PubMed  Google Scholar 

  75. Casas, R. et al. The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS ONE 9, e100084 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  76. Firth, J. et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom. Med. 81, 265–280 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  77. Longo, V. D. et al. Interventions to slow aging in humans: are we ready? Aging Cell 14, 497–510 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. de Cabo, R. & Mattson, M. P. Effects of intermittent fasting on health, aging, and disease. N. Engl. J. Med. 381, 2541–2551 (2019).

    Article  PubMed  Google Scholar 

  79. Mercken, E. M. et al. Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 12, 645–651 (2013).

    Article  CAS  PubMed  Google Scholar 

  80. Kittana, M., Apostolopoulos, V. & Stojanovska, L. in Biochemistry and Cell Biology of Ageing: Part V, Anti-Ageing Interventions (eds Korolchuk, V. I. & Harris, J. R.) 173–181 (Springer, 2024).

  81. Trichopoulou, A. et al. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 12, 112 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  82. Fadnes, L. T., Økland, J.-M., Haaland, Ø. A. & Johansson, K. A. Estimating impact of food choices on life expectancy: a modeling study. PLoS Med. 19, e1003889 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  83. Kahleova, H., Levin, S. & Barnard, N. Cardio-metabolic benefits of plant-based diets. Nutrients 9, 848 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  84. Casas, R. et al. Long-term immunomodulatory effects of a Mediterranean diet in adults at high risk of cardiovascular disease in the Prevención con Dieta Mediterránea (PREDIMED) randomized controlled trial. J. Nutr. 146, 1684–1693 (2016).

    Article  CAS  PubMed  Google Scholar 

  85. Margină, D. et al. Chronic inflammation in the context of everyday life: dietary changes as mitigating factors. Int. J. Environ. Res. Public Health 17, 4135 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  86. Berendsen, A. et al. A parallel randomized trial on the effect of a healthful diet on inflammageing and its consequences in European elderly people: design of the NU-AGE dietary intervention study. Mech. Ageing Dev. 134, 523–530 (2013).

    Article  PubMed  Google Scholar 

  87. Santoro, A. et al. Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project’s conceptual framework and design. Mech. Ageing Dev. 136–137, 3–13 (2014).

    Article  PubMed  Google Scholar 

  88. Ostan, R. et al. Cross-sectional analysis of the correlation between daily nutrient intake assessed by 7-day food records and biomarkers of dietary intake among participants of the NU-AGE study. Front. Physiol. 9, 1359 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  89. Berendsen, A. A. M. et al. Changes in dietary intake and adherence to the NU-AGE diet following a one-year dietary intervention among European older adults—results of the NU-AGE randomized trial. Nutrients 10, 1905 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  90. Marseglia, A. et al. Effect of the NU-AGE diet on cognitive functioning in older adults: a randomized controlled trial. Front. Physiol. 9, 349 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  91. Jennings, A. et al. A Mediterranean-like dietary pattern with vitamin D3 (10 µg/d) supplements reduced the rate of bone loss in older Europeans with osteoporosis at baseline: results of a 1-y randomized controlled trial. Am. J. Clin. Nutr. 108, 633–640 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  92. Maijo, M. et al. One-year consumption of a Mediterranean-like dietary pattern with vitamin D3 supplements induced small scale but extensive changes of immune cell phenotype, co-receptor expression and innate immune responses in healthy elderly subjects: results from the United Kingdom arm of the NU-AGE trial. Front. Physiol. 9, 997 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  93. van Soest, A. P. M. et al. Associations between pro- and anti-inflammatory gastro-intestinal microbiota, diet, and cognitive functioning in Dutch healthy older adults: the NU-AGE study. Nutrients 12, 3471 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  94. Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5, e10667 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  95. Golshany, H. et al. The gut microbiome across the lifespan: how diet modulates our microbial ecosystem from infancy to the elderly. Int. J. Food Sci. Nutr. 76, 95–121 (2024).

  96. Lazou-Ahrén, I. et al. Probiotic-reduced inflammaging in older adults: a randomized, double-blind, placebo-controlled trial. Probiotics Antimicrob. Proteins https://doi.org/10.1007/s12602-024-10310-7 (2024).

    Article  PubMed  Google Scholar 

  97. Roberts, J. L. et al. Bifidobacterium longum supplementation improves age‐related delays in fracture repair. Aging Cell 22, e13786 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Wang, X., Wang, T., Zhang, Q., Xu, L. & Xiao, X. Dietary supplementation with inulin modulates the gut microbiota and improves insulin sensitivity in prediabetes. Int. J. Endocrinol. 2021, 5579369 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  99. Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184 (2012).

    Article  CAS  PubMed  Google Scholar 

  100. Liu, T. et al. Hesperidin and fecal microbiota transplantation modulate the composition of the gut microbiota and reduce obesity in high fat diet mice. Diabetes Metab. Syndr. Obes. 17, 3643–3656 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  101. Novelle, M. G., Naranjo-Martínez, B., López-Cánovas, J. L. & Díaz-Ruiz, A. Fecal microbiota transplantation, a tool to transfer healthy longevity. Ageing Res. Rev. 103, 102585 (2025).

    Article  CAS  PubMed  Google Scholar 

  102. Santoro, A. et al. A cross-sectional analysis of body composition among healthy elderly from the European NU-AGE study: sex and country specific features. Front. Physiol. 9, 1693 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  103. Santoro, A. et al. Gender-specific association of body composition with inflammatory and adipose-related markers in healthy elderly Europeans from the NU-AGE study. Eur. Radiol. 29, 4968–4979 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  104. Ribeiro, I. S. et al. Regular physical activity reduces the effects of inflammaging in diabetic and hypertensive men. Exp. Gerontol. 155, 111558 (2021).

    Article  CAS  PubMed  Google Scholar 

  105. Antuña, E. et al. Inflammaging: implications in sarcopenia. Int. J. Mol. Sci. 23, 15039 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  106. Izquierdo, M. et al. Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR). J. Nutr. Health Aging 29, 100401 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  107. Duggal, N. A., Pollock, R. D., Lazarus, N. R., Harridge, S. & Lord, J. M. Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood. Aging Cell 17, e12750 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  108. Moradell, A., Casajús, J. A., Moreno, L. A. & Vicente-Rodríguez, G. Perspectives on diet and exercise interaction for healthy aging: opportunities to reduce malnutrition risk and optimize fitness. Nutrients 17, 596 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Petersen, A. M. W. & Pedersen, B. K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98, 1154–1162 (2005).

    Article  CAS  PubMed  Google Scholar 

  110. Docherty, S. et al. The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review. BMC Sports Sci. Med. Rehabil. 14, 5 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  111. Farley, M. J. et al. Interleukin‐15 and high‐intensity exercise: relationship with inflammation, body composition and fitness in cancer survivors. J. Physiol. 602, 5203–5215 (2024).

    Article  CAS  PubMed  Google Scholar 

  112. Ringleb, M. et al. Beyond muscles: investigating immunoregulatory myokines in acute resistance exercise — a systematic review and meta‐analysis. FASEB J. 38, e23596 (2024).

    Article  CAS  PubMed  Google Scholar 

  113. Forcina, L., Franceschi, C. & Musarò, A. The hormetic and hermetic role of IL-6. Ageing Res. Rev. 80, 101697 (2022).

    Article  CAS  PubMed  Google Scholar 

  114. Nilsson, M. I. et al. Lifelong aerobic exercise protects against inflammaging and cancer. PLoS ONE 14, e0210863 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Hayes, L. D., Herbert, P., Sculthorpe, N. F. & Grace, F. M. Short-term and lifelong exercise training lowers inflammatory mediators in older men. Front. Physiol. 12, 702248 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  116. Ferreira, R. Z. et al. Effects of strength training with free weights and elastic resistance in older adults: a randomised clinical study. J. Bodyw. Mov. Ther. 41, 48–55 (2025).

    Article  PubMed  Google Scholar 

  117. Sallam, N. & Laher, I. Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases. Oxid. Med. Cell. Longev. 2016, 7239639 (2016).

    Article  PubMed  Google Scholar 

  118. Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K. & Jensen, J. Effect of exercise training on fat loss—energetic perspectives and the role of improved adipose tissue function and body fat distribution. Front. Physiol. 12, 737709 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  119. Couvert, A. et al. Effects of a cycling versus running HIIT program on fat mass loss and gut microbiota composition in men with overweight/obesity. Med. Sci. Sports Exerc. 56, 839–850 (2024).

    Article  CAS  PubMed  Google Scholar 

  120. Lavin, K. M. et al. Effects of aging and lifelong aerobic exercise on basal and exercise-induced inflammation in women. J. Appl. Physiol. 129, 1493–1504 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Perkins, R. K. et al. Effects of aging and lifelong aerobic exercise on expression of innate immune components in skeletal muscle of women. J. Appl. Physiol. 136, 482–491 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Saponaro, F. et al. Myokines and microbiota: new perspectives in the endocrine muscle–gut axis. Nutrients 16, 4032 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Tavella, T. et al. Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes 13, 1–19 (2021).

    Article  PubMed  Google Scholar 

  124. Nejati Bervanlou, R., Hlaváčová, N., Figueiredo, V. C., Attarzadeh Hosseini, S. R. & Motahari Rad, M. The impact of exercise and protein intake on inflammaging: a meta-analysis and systematic review of randomized controlled trials. Nutr. Rev. 83, e1458–e1471 (2024).

    Article  Google Scholar 

  125. Mantzorou, M. et al. Mediterranean diet adherence is associated with favorable health-related quality of life, physical activity, and sleep quality in a community-dwelling Greek older population. Antioxidants 12, 983 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Piber, D. et al. Sleep disturbance and activation of cellular and transcriptional mechanisms of inflammation in older adults. Brain Behav. Immun. 106, 67–75 (2022).

    Article  CAS  PubMed  Google Scholar 

  127. Singh, K. K. et al. Sleep and immune system crosstalk: implications for inflammatory homeostasis and disease pathogenesis. Ann. Neurosci. 32, 196–206 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  128. Rim, C., You, M.-J., Nahm, M. & Kwon, M.-S. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl. Neurodegener. 13, 10 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  129. Gudkov, S. V. et al. An emerging role of astrocytes in aging/neuroinflammation and gut–brain axis with consequences on sleep and sleep disorders. Ageing Res. Rev. 83, 101775 (2023).

    Article  CAS  PubMed  Google Scholar 

  130. Xiong, Y. et al. Advances in the study of the glymphatic system and aging. CNS Neurosci. Ther. 30, e14803 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Gordleeva, S., Kanakov, O., Ivanchenko, M., Zaikin, A. & Franceschi, C. Brain aging and garbage cleaning. Semin. Immunopathol. 42, 647–665 (2020).

    Article  PubMed  Google Scholar 

  132. Krivonosov, M. I. et al. Correction to: A new cognitive clock matching phenotypic and epigenetic ages. Transl. Psychiatry 12, 452 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Brewster, G. S., Riegel, B. & Gehrman, P. R. Insomnia in the older adult. Sleep Med. Clin. 17, 233–239 (2022).

    Article  PubMed  Google Scholar 

  134. Barone, M. et al. Towards a personalized prediction, prevention and therapy of insomnia: gut microbiota profile can discriminate between paradoxical and objective insomnia in post-menopausal women. EPMA J. 15, 471–489 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  135. Ratiner, K., Ciocan, D., Abdeen, S. K. & Elinav, E. Utilization of the microbiome in personalized medicine. Nat. Rev. Microbiol. 22, 291–308 (2024).

    Article  CAS  PubMed  Google Scholar 

  136. Moskalev, A. et al. Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell 15, 407–415 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. He, C. et al. Enhanced longevity by ibuprofen, conserved in multiple species, occurs in yeast through inhibition of tryptophan import. PLoS Genet. 10, e1004860 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  138. Danilov, A. et al. Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity. Oncotarget 6, 19428–19444 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  139. Rivero-Segura, N. A. et al. Exploring the geroprotective potential of nutraceuticals. Nutrients 16, 2835 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Proshkina, E. et al. Polyphenols as potential geroprotectors. Antioxid. Redox Signal. 40, 564–593 (2024).

    Article  CAS  PubMed  Google Scholar 

  141. Proshkina, E. et al. Terpenoids as potential geroprotectors. Antioxidants 9, 529 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Landsberger, T., Amit, I. & Alon, U. Geroprotective interventions converge on gene expression programs of reduced inflammation and restored fatty acid metabolism. Geroscience 46, 1627–1639 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  143. Justice, J. N. et al. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. Geroscience 40, 419–436 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Wang, J. et al. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome. Medicine 96, e8183 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Moskalev, A. A. & Shaposhnikov, M. V. Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster. Rejuvenation Res. 13, 246–247 (2010).

    Article  CAS  PubMed  Google Scholar 

  146. Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Konopka, A. R. et al. Blazing a trail for the clinical use of rapamycin as a geroprotecTOR. Geroscience 45, 2769–2783 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  148. Mandrioli, J. et al. Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis. Nat. Commun. 14, 4970 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  149. Niechcial, A. et al. Spermidine ameliorates colitis via induction of anti-inflammatory macrophages and prevention of intestinal dysbiosis. J. Crohns Colitis 17, 1489–1503 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  150. Ji, S. et al. Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. Signal Transduct. Target. Ther. 8, 116 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  151. Ma, S. et al. Heterochronic parabiosis induces stem cell revitalization and systemic rejuvenation across aged tissues. Cell Stem Cell 29, 990–1005 (2022).

    Article  CAS  PubMed  Google Scholar 

  152. Robbins, P. D. et al. Senolytic drugs: reducing senescent cell viability to extend health span. Annu. Rev. Pharmacol. Toxicol. 61, 779–803 (2021).

    Article  CAS  PubMed  Google Scholar 

  153. Krzystyniak, A. et al. Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile. Aging 14, 572–595 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Farheen, S. et al. Patho-physiology of aging and immune-senescence: possible correlates with comorbidity and mortality in middle-aged and old COVID-19 patients. Front. Aging 2, 748591 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  155. Hernández-Silva, D. et al. Senescence-independent anti-inflammatory activity of the senolytic drugs dasatinib, navitoclax, and venetoclax in zebrafish models of chronic inflammation. Int. J. Mol. Sci. 23, 10468 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  156. Kirkland, J. L. & Tchkonia, T. Senolytic drugs: from discovery to translation. J. Intern. Med. 288, 518–536 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Hickson, L. J. et al. Corrigendum to ‘Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456. EBioMedicine 52, 102595 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  158. Carpenter, V. J., Saleh, T. & Gewirtz, D. A. Senolytics for cancer therapy: is all that glitters really gold? Cancers 13, 723 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Batista, M. A. et al. Inflammaging in endemic areas for infectious diseases. Front. Immunol. 11, 579972 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  160. Franck, M. et al. Nonuniversality of inflammaging across human populations. Nat. Aging. https://doi.org/10.1038/s43587-025-00888-0 (2025).

  161. Nie, C. et al. Distinct biological ages of organs and systems identified from a multi-omics study. Cell Rep. 38, 110459 (2022).

    Article  CAS  PubMed  Google Scholar 

  162. Bracken, O. V., De Maeyer, R. P. H. & Akbar, A. N. Enhancing immunity during ageing by targeting interactions within the tissue environment. Nat. Rev. Drug Discov. 24, 300–315 (2025).

    Article  CAS  PubMed  Google Scholar 

  163. Andonian, B. J. et al. Inflammation and aging-related disease: a transdisciplinary inflammaging framework. Geroscience 47, 515–542 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  164. Capri, M. et al. Long-term human spaceflight and inflammaging: does it promote aging? Ageing Res. Rev. 87, 101909 (2023).

    Article  CAS  PubMed  Google Scholar 

  165. Mohammadian, A. et al. The effect of acarbose on inflammatory cytokines and adipokines in adults: a systematic review and meta-analysis of randomized clinical trials. Inflammopharmacology 32, 355–376 (2024).

    Article  CAS  PubMed  Google Scholar 

  166. Islam, M. T. et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging Cell 22, e13767 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  167. Kalyakulina, A. et al. Small immunological clocks identified by deep learning and gradient boosting. Front. Immunol. 14, 1177611 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  168. Nauta, M. et al. From anecdotal evidence to quantitative evaluation methods: a systematic review on evaluating explainable AI. ACM Comput. Surv. 55, 1–42 (2023).

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by funding from the Italian Ministry of Health ‘Ricerca Corrente’ to IRCCS INRCA and by Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8, Project Age-It: ‘Ageing Well in an Ageing Society’ to F.O. The views and opinions expressed are only those of the authors and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them. This work was also supported by the Ministry of Economic Development of the Russian Federation (grant no. 139-15-2025-004 dated 17 April 2025, agreement identifier 000000С313925P3X0002) to M.I. We thank M. Marzio (IRCCS INRCA, Ancona, Italy) for drawing Figs. 1, 3 and 4; I. Yusipov and A. Kalyakulina (Lobachevsky University, Nizhny Novgorod, Russia) for preparing Fig. 2 and L.S. Jurado-Medina (University of Bologna, Bologna, Italy) for checking the text and preparing the reference list.

Author information

Authors and Affiliations

Authors

Contributions

C.F. and A.S. conceived the Review and wrote the first draft of the manuscript. F.O., A.M. and M.I. provided constructive input and wrote additional sections in subsequent revisions of the manuscript. All authors approved the final version of the Review and its tables, box and figures.

Corresponding authors

Correspondence to Fabiola Olivieri or Aurelia Santoro.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Aging thanks Niharika Duggal and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Franceschi, C., Olivieri, F., Moskalev, A. et al. Toward precision interventions and metrics of inflammaging. Nat Aging 5, 1441–1454 (2025). https://doi.org/10.1038/s43587-025-00938-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43587-025-00938-7

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing